Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Asset Utilization Ratio (2020 - 2024)

Benitec Biopharma's Asset Utilization Ratio history spans 4 years, with the latest figure at 0.0 for Q4 2023.

  • For Q4 2023, Asset Utilization Ratio changed N/A year-over-year to 0.0; the TTM value through Dec 2023 reached 0.0, changed N/A, while the annual FY2023 figure was 0.01, 169.25% up from the prior year.
  • Asset Utilization Ratio for Q4 2023 was 0.0 at Benitec Biopharma, down from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.01 in Q3 2020 and bottomed at 0.0 in Q1 2021.
  • The 4-year median for Asset Utilization Ratio is 0.0 (2020), against an average of 0.0.
  • The largest YoY upside for Asset Utilization Ratio was 21.48% in 2023 against a maximum downside of 21.48% in 2023.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.0 in 2020, then decreased by 3.7% to 0.0 in 2021, then soared by 78.79% to 0.01 in 2022, then tumbled by 58.42% to 0.0 in 2023.
  • Per Business Quant, the three most recent readings for BNTC's Asset Utilization Ratio are 0.0 (Q4 2023), 0.0 (Q3 2023), and 0.01 (Q3 2022).